The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy.

[1]  B. McCarl,et al.  Economics , 1870, The Indian medical gazette.

[2]  R. Hartsock,et al.  Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception. , 1982, Journal of the National Cancer Institute.

[3]  L. McWilliam,et al.  Sarcomas in north west England: I. Histopathological peer review. , 1991, British Journal of Cancer.

[4]  P. Walsh,et al.  Relationship Between Perineural Tumor Invasion on Needle Biopsy and Radical Prostatectomy Capsular Penetration in Clinical Stage B Adenocarcinoma of the Prostate , 1993, The American journal of surgical pathology.

[5]  D. Raghavan,et al.  The impact of histological review on clinical management of testicular cancer. , 1993, British journal of urology.

[6]  The institutional pathology consultation. Documentation of its importance in patient management. , 1995 .

[7]  The institutional pathology consultation. Documentation of its importance in patient management. , 1995, Archives of pathology & laboratory medicine.

[8]  S. Banerjee,et al.  Audit of tumour histopathology reviewed by a regional oncology centre. , 1995, Journal of clinical pathology.

[9]  A. Abt,et al.  The effect of interinstitution anatomic pathology consultation on patient care. , 1995, Archives of pathology & laboratory medicine.

[10]  P. Walsh,et al.  Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. , 1996, The American journal of surgical pathology.

[11]  P. Goldschmidt,et al.  What is proper cancer care in the era of managed care? , 1997, Oncology.

[12]  D. Bostwick,et al.  Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[13]  A. Patchefsky,et al.  Histopathologic review of prostate biopsies from patients referred to a comprehensive cancer center , 1998, Cancer.

[14]  Interinstitutional Surgical Pathology Review in Gynecologic Oncology II. Endometrial Cancer in Hysterectomy Specimens , 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[15]  D. Chan,et al.  Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. , 1998, The Journal of urology.

[16]  A. Selman,et al.  Quality assurance of second opinion pathology in gynecologic oncology. , 1999, Obstetrics and gynecology.

[17]  R. Pearcey,et al.  An analysis of the impact of pathology review in gynecologic cancer. , 2000, International journal of radiation oncology, biology, physics.

[18]  R. Sirota,et al.  Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome , 2000, Cancer.

[19]  L. Layfield,et al.  Prevalence of inter-institutional anatomic pathology slide review: a survey of current practice. , 2000, The American journal of surgical pathology.

[20]  A. Patchefsky,et al.  Clinical Significance of Performing Immunohistochemistry on Cases With a Previous Diagnosis of Cancer Coming to a National Comprehensive Cancer Center for Treatment or Second Opinion , 2002, The American journal of surgical pathology.

[21]  Review of 'outside' pathology before treatment should be mandatory. , 2002, The American journal of surgical pathology.

[22]  J. Epstein,et al.  Threshold for diagnosing prostate cancer over time. , 2003, Human pathology.

[23]  P. Humphrey,et al.  Multiple Measures of Carcinoma Extent Versus Perineural Invasion in Prostate Needle Biopsy Tissue in Prediction of Pathologic Stage in a Screening Population , 2003, The American journal of surgical pathology.

[24]  T. Colgan,et al.  Interinstitutional pathology consultations. A reassessment. , 2003, American journal of clinical pathology.

[25]  L. Egevad,et al.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.

[26]  Carys W Thomas,et al.  Clinical impact of second pathology opinion: a longitudinal study of central genitourinary pathology review before prostate brachytherapy. , 2007, Brachytherapy.

[27]  P. Humphrey,et al.  Prognostic value of various morphometric measurements of tumour extent in prostate needle core tissue , 2008, Histopathology.

[28]  Ximing J. Yang,et al.  Grading of Invasive Cribriform Carcinoma on Prostate Needle Biopsy: An Interobserver Study among Experts in Genitourinary Pathology , 2008, The American journal of surgical pathology.

[29]  J. Epstein,et al.  Fragmentation of prostatic needle biopsy cores containing adenocarcinoma: the role of specimen submission , 2010, BJU international.

[30]  P. Kay,et al.  Second opinion pathology in tertiary care of patients with urologic malignancies. , 2011, Urologic oncology.